North America e-clinical solutions market is expected to reach USD 8,167.32 million by 2030 from USD 2,769.17 million in 2022, growing with a CAGR of 14.5% during the forecast period from 2023 to 2030. Market Segmentation: North America e-Clinical Solutions Market, By Product (Electronic Data Capture and Clinical Data Management Systems, Randomization and Trial Supply Management, Clinical Trial Management Systems, Electronic Trial Master File Systems, Electronic Clinical Outcome Assessment Solutions, Safety Solutions, Regulatory Information Management Solutions, Clinical Data Integration Platforms, Clinical Analytics Platforms, Care Coordination Medical Record (CCMR), and Others), Delivery Mode (Web-Hosted (On-Demand) Solutions, Cloud-Based (SaaS) Solutions, and Licensed Enterprise (On-Premises) Solutions), Clinical Trial Phase (Phase I, Phase II, Phase III, and Phase IV), Organization Size (Medium and small, and Large), User Device (Desktop, Tablet, Smart Phone, Handheld PDA Device, and Others), End User (Contract Research Organizations, Pharmaceutical and Biopharmaceutical Companies, Medical Device Manufacturers, Hospital, Consulting Service Companies, and Academic Research Institutes) Industry Trends and Forecast to 2030. Overview of North America e-Clinical Solutions Market Dynamics : Driver • The growing usage of e-clinical solutions in clinical trials Restraint • Data safety and privacy issues Opportunity • Rising adoption of electronic data capture (EDC) systems and cloud-based solutions Market Players: Some of the key market players operating in the North America e-clinical solutions market are listed below: • Clario • Oracle • OpenClinica, LLC • Dassault Systèmes • Signant Health • MaxisIT® • PAREXEL INTERNATIONAL CORPORATION • Mednet • 4G Clinical • Saama Technologies, LLC. • ANJU SOFTWARE (PORTFOLIO COMPANY OF ABRY PARTNERS) • Veeva Systems • Medrio, Inc. • Castor • ArisGlobal • Merative • Advarra • RealTime Software Solutions, LLC • Y-Prime, LLC. • eClinical Solutions LLC. • Datatrak Int. • IQVIA Inc

1 INTRODUCTION 24 1.1 OBJECTIVES OF THE STUDY 24 1.2 MARKET DEFINITION 24 1.3 OVERVIEW 24 1.4 CURRENCY AND PRICING 26 1.5 LIMITATIONS 26 1.6 MARKETS COVERED 26 2 MARKET SEGMENTATION 29 2.1 MARKETS COVERED 29 2.2 GEOGRAPHICAL SCOPE 30 2.3 YEARS CONSIDERED FOR THE STUDY 31 2.4 DBMR TRIPOD DATA VALIDATION MODEL 32 2.5 PRIMARY INTERVIEWS WITH KEY OPINION LEADERS 35 2.6 MULTIVARIATE MODELLING 36 2.7 MARKET END USER COVERAGE GRID 37 2.8 PRODUCT LIFELINE CURVE 38 2.9 DBMR MARKET POSITION GRID 39 2.10 VENDOR SHARE ANALYSIS 40 2.11 SECONDARY SOURCES 41 2.12 ASSUMPTIONS 41 3 EXECUTIVE SUMMARY 42 4 PREMIUM INSIGHTS 45 4.1 PORTER'S FIVE FORCES MODEL 46 4.2 ECOSYSTEMS ANALYSIS OF E CLINICAL SOLUTIONS 47 4.3 USE CASES 49 5 VALUE CHAIN ANALYSIS 50 6 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET: REGULATIONS 51 7 MARKET OVERVIEW 57 7.1 DRIVERS 59 7.1.1 THE GROWING USAGE OF E-CLINICAL SOLUTIONS IN CLINICAL TRIALS 59 7.1.2 INCREASING R&D ACTIVITIES AND CORRESPONDING EXPENDITURE 59 7.1.3 STRATEGIC INITIATIVES TAKEN BY MAJOR BIOTECHNOLOGY AND PHARMACEUTICAL COMPANIES 60 7.1.4 IMPROVED HEALTHCARE INFRASTRUCTURE AND ESTABLISHMENT OF ADVANCED LABORATORIES 60 7.2 RESTRAINTS 61 7.2.1 DATA SAFETY AND PRIVACY ISSUES 61 7.2.2 LACK OF SKILLED PROFESSIONALS 61 7.2.3 LIMITED ADOPTION OF E-CLINICAL SOLUTIONS IN EMERGING COUNTRIES DUE TO BUDGETARY CONSTRAINTS AND POOR MANAGEMENT POLICIES 62 7.3 OPPORTUNITIES 62 7.3.1 RISING ADOPTION OF ELECTRONIC DATA CAPTURE (EDC) SYSTEMS AND CLOUD-BASED SOLUTIONS 62 7.3.2 INCREASING INVESTMENTS BY VARIOUS GOVERNMENTS IN CLINICAL TRIALS 63 7.3.3 GROWING FOCUS ON PATIENT-CENTRIC CLINICAL TRIALS 63 7.4 CHALLENGES 64 7.4.1 REGULATORY CHALLENGES ASSOCIATED WITH E-CLINICAL SOLUTIONS 64 7.4.2 HIGH IMPLEMENTATION COSTS 64 8 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY PRODUCT 66 8.1 OVERVIEW 67 8.2 ELECTRONIC DATA CAPTURE AND CLINICAL DATA MANAGEMENT SYSTEMS 70 8.3 RANDOMIZATION AND TRIAL SUPPLY MANAGEMENT 71 8.4 CLINICAL TRIAL MANAGEMENT SYSTEMS 72 8.5 ELECTRONIC TRIAL MASTER FILE SYSTEMS 73 8.6 ELECTRONIC CLINICAL OUTCOME ASSESSMENT SOLUTIONS 74 8.7 SAFETY SOLUTIONS 75 8.8 REGULATORY INFORMATION MANAGEMENT SOLUTIONS 76 8.9 CLINICAL DATA INTEGRATION PLATFORMS 77 8.10 CLINICAL ANALYTICS PLATFORMS 78 8.11 CARE COORDINATION MEDICAL RECORD (CCMR) 79 8.12 OTHERS 80 9 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY DELIVERY MODE 82 9.1 OVERVIEW 83 9.2 WEB-HOSTED (ON-DEMAND) SOLUTIONS 86 9.3 CLOUD-BASED (SAAS) SOLUTIONS 86 9.4 LICENSED ENTERPRISE (ON-PREMISES) SOLUTIONS 87 10 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY CLINICAL TRIAL PHASE 89 10.1 OVERVIEW 90 10.2 PHASE III 93 10.3 PHASE I 93 10.4 PHASE II 94 10.5 PHASE IV 95 11 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY ORGANIZATION SIZE 96 11.1 OVERVIEW 97 11.2 MEDIUM AND SMALL 100 11.3 LARGE 101 12 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY USER DEVICE 102 12.1 OVERVIEW 103 12.2 DESKTOP 106 12.3 TABLET 106 12.4 SMART PHONE 107 12.5 HANDHELD PDA DEVICE 108 12.6 OTHERS 108 13 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY END USER 110 13.1 OVERVIEW 111 13.2 CONTRACT RESEARCH ORGANIZATIONS 114 13.3 PHARMACEUTICAL AND BIOPHARMACEUTICAL COMPANIES 114 13.4 MEDICAL DEVICE MANUFACTURERS 115 13.5 HOSPITAL 116 13.6 CONSULTING SERVICE COMPANIES 116 13.7 ACADEMIC RESEARCH INSTITUTES 117 14 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, BY REGION 118 14.1 NORTH AMERICA 119 14.1.1 U.S 126 14.1.2 CANADA 129 14.1.3 MEXICO 132 15 NORTH AMERICA E-CLINICAL SOLUTIONS MARKET, COMPANY LANDSCAPE 135 15.1 COMPANY SHARE ANALYSIS: NORTH AMERICA 135 16 SWOT ANALYSIS 136 17 COMPANY PROFILE 137 17.1 ORACLE 137 17.1.1 COMPANY SNAPSHOT 137 17.1.2 REVENUE ANALYSIS 137 17.1.3 COMPANY SHARE ANALYSIS 138 17.1.4 PRODUCT PORTFOLIO 138 17.1.5 RECENT DEVELOPMENT 138 17.2 DASSAULT SYSTEMES 139 17.2.1 COMPANY SNAPSHOT 139 17.2.2 REVENUE ANALYSIS 139 17.2.3 COMPANY SHARE ANALYSIS 140 17.2.4 PRODUCT PORTFOLIO 140 17.2.5 RECENT DEVELOPMENTS 141 17.3 CLARIO 142 17.3.1 COMPANY SNAPSHOT 142 17.3.2 COMPANY SHARE ANALYSIS 142 17.3.3 PRODUCT PORTFOLIO 143 17.3.4 RECENT DEVELOPMENT 143 17.4 VEEVA SYSTEMS 144 17.4.1 COMPANY SNAPSHOT 144 17.4.2 REVENUE ANALYSIS 144 17.4.3 COMPANY SHARE ANALYSIS 145 17.4.4 PRODUCT PORTFOLIO 145 17.4.5 RECENT DEVELOPMENTS 146 17.5 ARISNORTH AMERICA 147 17.5.1 COMPANY SNAPSHOT 147 17.5.2 COMPANY SHARE ANALYSIS 147 17.5.3 PRODUCT PORTFOLIO 148 17.5.4 RECENT DEVELOPMENTS 148 17.6 4G CLINICAL 149 17.6.1 COMPANY SNAPSHOT 149 17.6.2 PRODUCT PORTFOLIO 149 17.6.3 RECENT DEVELOPMENT 149 17.7 ADVARRA 150 17.7.1 COMPANY SNAPSHOT 150 17.7.2 PRODUCT PORTFOLIO 150 17.7.3 RECENT DEVELOPMENT 150 17.8 ANJU 151 17.8.1 COMPANY SNAPSHOT 151 17.8.2 PRODUCT PORTFOLIO 151 17.8.3 RECENT DEVELOPMENTS 152 17.9 CASTOR 153 17.9.1 COMPANY SNAPSHOT 153 17.9.2 PRODUCT PORTFOLIO 153 17.9.3 RECENT DEVELOPMENTS 153 17.10 DATATRAK INT 154 17.10.1 COMPANY SNAPSHOT 154 17.10.2 PRODUCT PORTFOLIO 154 17.10.3 RECENT DEVELOPMENT 154 17.11 ECLINICAL SOLUTIONS LLC 155 17.11.1 COMPANY SNAPSHOT 155 17.11.2 PRODUCT PORTFOLIO 155 17.11.3 RECENT DEVELOPMENT 155 17.12 IQVIA INC 156 17.12.1 COMPANY SNAPSHOT 156 17.12.2 REVENUE ANALYSIS 156 17.12.3 PRODUCT PORTFOLIO 157 17.12.4 RECENT DEVELOPMENTS 157 17.13 MAXISIT 158 17.13.1 COMPANY SNAPSHOT 158 17.13.2 PRODUCT PORTFOLIO 158 17.13.3 RECENT DEVELOPMENT 159 17.14 MEDNET 160 17.14.1 COMPANY SNAPSHOT 160 17.14.2 PRODUCT PORTFOLIO 160 17.14.3 RECENT DEVELOPMENT 161 17.15 MEDRIO, INC 162 17.15.1 COMPANY SNAPSHOT 162 17.15.2 PRODUCT PORTFOLIO 162 17.15.3 RECENT DEVELOPMENTS 163 17.16 MERATIVE 164 17.16.1 COMPANY SNAPSHOT 164 17.16.2 PRODUCT PORTFOLIO 164 17.16.3 RECENT DEVELOPMENT 164 17.17 OPENCLINICA, LLC 165 17.17.1 COMPANY SNAPSHOT 165 17.17.2 PRODUCT PORTFOLIO 165 17.17.3 RECENT DEVELOPMENT 165 17.18 PAREXEL INTERNATIONAL CORPORATION 166 17.18.1 COMPANY SNAPSHOT 166 17.18.2 PRODUCT PORTFOLIO 166 17.18.3 RECENT DEVELOPMENT 166 17.19 QURETEC 167 17.19.1 COMPANY SNAPSHOT 167 17.19.2 PRODUCT PORTFOLIO 167 17.19.3 RECENT DEVELOPMENT 167 17.20 REALTIME SOFTWARE SOLUTIONS, LLC 168 17.20.1 COMPANY SNAPSHOT 168 17.20.2 PRODUCT PORTFOLIO 168 17.20.3 RECENT DEVELOPMENT 168 17.21 RESEARCH MANAGER 169 17.21.1 COMPANY SNAPSHOT 169 17.21.2 PRODUCT PORTFOLIO 169 17.21.3 RECENT DEVELOPMENT 169 17.22 SAAMA TECHNOLOGIES, LLC 170 17.22.1 COMPANY SNAPSHOT 170 17.22.2 PRODUCT PORTFOLIO 170 17.22.3 RECENT DEVELOPMENT 170 17.23 SIGNANT HEALTH 171 17.23.1 COMPANY SNAPSHOT 171 17.23.2 PRODUCT PORTFOLIO 171 17.23.3 RECENT DEVELOPMENT 171 17.24 Y-PRIME, LLC 172 17.24.1 COMPANY SNAPSHOT 172 17.24.2 PRODUCT PORTFOLIO 172 17.24.3 RECENT DEVELOPMENT 172 18 QUESTIONNAIRE 173 19 RELATED REPORTS 176